These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3482884)

  • 1. [Immunochemotherapy of mice S-180 ascitic tumor by combination of cyclophosphamide and BCG].
    Chiou CY; Wong YH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1986 Mar; 2(3):164-71. PubMed ID: 3482884
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the combined treatment with cyclophosphamide and virus in mice transplanted with S180 ascitic tumor cells].
    Jia FL; Huang CH; Cai J; Li Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Oct; 7(5):376-9. PubMed ID: 2938760
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of M.bovis BCG and M.microti on sarcoma 180 growth in mice.
    Nedvĕdová V; Sír Z; Hyncica V; Buresová M
    Neoplasma; 1978; 25(6):685-90. PubMed ID: 377109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of hot-water extract from delipidated BCG.
    Sato H; Yokosawa A; Arai H; Nagai H; Kumano N; Motomiya M; Konno K
    Tohoku J Exp Med; 1978 Jul; 125(3):247-52. PubMed ID: 358496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose inhibition and low-dose enhancement of murine sarcoma growth exhibited by BCG vaccine.
    Klegerman ME; Ujjainwala L; Zeunert P
    Cancer Lett; 1991 Feb; 56(2):137-45. PubMed ID: 1998942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of BCG as immunoadjuvant in combination with antitumor drugs in a virus induced leukemia. II].
    Perito S; Cenci E; Sbaraglia G; Vecchiarelli A
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2511-7. PubMed ID: 7470294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumor growth and regression of established tumor with oil-attached mycobacterial fractions.
    Yamamura Y; Azuma I; Taniyama T; Ribi E; Zbar B
    Gan; 1974 Apr; 65(2):179-81. PubMed ID: 4209836
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemoimmune prophylaxis of superficial bladder carcinoma with cyclophosphamide and BCG.
    Jaeger N; Adolphs HD; Vahlensieck W
    Prog Clin Biol Res; 1989; 303():393-9. PubMed ID: 2780655
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of immunostimulating and immunotherapeutic effect of BCG vaccines using listerial endotoxin-like substances.
    Mára M; Průchová J; Smerák P; John C; Miková Z; Nedvĕdová V; Sir Z
    Dev Biol Stand; 1986; 58 ( Pt A)():379-87. PubMed ID: 3596044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparison of the therapeutic effects of high and low dosages of cyclophosphamide on mice bearing various growth intervals of S-180 subcutaneous tumors].
    Chiou CY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Sep; 3(9):569-74. PubMed ID: 3483020
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of modifiers of natural biological response on the functional activity of macrophages (oncological aspect)].
    Gromov SA; Voĭtenkov BO; Okulov VB
    Antibiot Khimioter; 1990 Feb; 35(2):29-33. PubMed ID: 2337372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of high-intensity electric pulse inhibited sarcoma for improving antitumor drug effect].
    Li H; Wang Z; Yue B; Zou F; Yang K; Sun J; Wang B; Zhang H; Chen H; Yang G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Dec; 20(4):612-4. PubMed ID: 14716858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukaemia and Lewis tumour.
    Mathé G; Halle-Pannenko O; Bourut C
    Eur J Cancer (1965); 1977 Oct; 13(10):1095-8. PubMed ID: 923609
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adoptive immunotherapy of the established S-180 ascitic tumor with the syngeneic normal splenic cells treated by the xenogeneic immune ribonucleic acid].
    Chiou CY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1985 Aug; 1(8):494-504. PubMed ID: 2454322
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative tumor inhibitory and stimulatory activities of BCG vaccine preparations, lots and substrains in a quantitative mouse sarcoma bioassay.
    Klegerman ME; Zeunert PL; Lajeune J; Lou Y; Groves MJ
    Anticancer Res; 1991; 11(5):1707-10. PubMed ID: 1768040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemia.
    Mathé G; Halle-Pannenko O; Bourut C
    Eur J Cancer (1965); 1974 Oct; 10(10):661-6. PubMed ID: 4465103
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nonspecific immunotherapy with BCG vaccine in bladder tumors].
    Damianov Kh; Patrashkov T; Petkov Ts; Tonchev T; Petrov P
    Khirurgiia (Sofiia); 1990; 43(1):48-53. PubMed ID: 2395285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental basis of chemotherapy-immunotherapy interspersion.
    Mathé G
    Antibiot Chemother (1971); 1978; 24():30-5. PubMed ID: 655678
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphological and functional characteristics of hemopoiesis during the combined use of cyclophosphane with millimeter-band radio waves of nonthermal intensity].
    Zubenkova ES; Borodkina AG; Zinov'ev SV; Sevast'ianova LA
    Farmakol Toksikol; 1985; 48(6):49-53. PubMed ID: 4085630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemo-immunoprevention in superficial bladder cancer].
    Adolphs HD; Bastian HP
    Urologe A; 1986 Jan; 25(1):51-4. PubMed ID: 3962045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.